Literature DB >> 26105994

China rejects patent on hepatitis C drug sofosbuvir.

Zosia Kmietowicz1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26105994     DOI： 10.1136/bmj.h3429

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.

Authors:  Céline Grillon; Priti R Krishtel; Othoman Mellouk; Anton Basenko; James Freeman; Luís Mendão; Isabelle Andrieux-Meyer; Sébastien Morin
Journal:  J Int AIDS Soc       Date:  2018-04       Impact factor: 5.396
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.